Abstract: Background: Pharmacovigilance (PV) is the science of detecting, assessing, and preventing adverse drug reactions (ADRs), which are often not fully recognised in pre-marketing clinical trials [85]. Objective: This review analyses the historical development of PV (1848–2025), comparing global milestones with Indian initiatives, and identifies future challenges and opportunities [86].
Rohan Eknath Bhagit (2025);
Adverse Drug Reactions and the Evolution of Pharmacovigilance: Comparative Insights from Global Systems and India (1848–2025);
International Journal of Scientific and Research Publications (IJSRP)
15(10) (ISSN: 2250-3153),
DOI: http://dx.doi.org/10.29322/IJSRP.15.10.2025.p16620
